E³ - Advanced Course: Hybrid Imaging

E³ 1119 - Guidelines and cost-effectiveness

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Wolfgang Gerhard Kunz, Munich / DE

2
PET/CT in lymphoma: guidelines

PET/CT in lymphoma: guidelines

23:00Manil Subesinghe, London / UK

3
PET/CT in lung cancer: guidelines

PET/CT in lung cancer: guidelines

23:00Wolfgang Gerhard Kunz, Munich / DE

4
Cost-effectiveness of hybrid imaging

Cost-effectiveness of hybrid imaging

20:00Wolfgang Gerhard Kunz, Munich / DE

E³ 1119-1
5 min
Chairperson's introduction
Wolfgang Gerhard Kunz, Munich / Germany
E³ 1119-2
23 min
PET/CT in lymphoma: guidelines
Manil Subesinghe, London / United Kingdom
  1. To summarise recommendations for staging and response assessment of lymphoma with FDG PET-CT as outlined in the Lugano classification.
  2. To confidently apply the 5-point scale (5-PS), i.e. Deauville criteria, when reporting response assessment FDG PET-CT.
  3. To demonstrate an understanding of the pitfalls of FDG PET-CT interpretation in lymphoma and their potential impact on clinical management.
E³ 1119-3
23 min
PET/CT in lung cancer: guidelines
Wolfgang Gerhard Kunz, Munich / Germany
  1. To identify the current value of FDG PET/CT for treatment decisions in lung cancer.
  2. To list the current position of FDG PET/CT in the current guidelines.
E³ 1119-4
20 min
Cost-effectiveness of hybrid imaging
Wolfgang Gerhard Kunz, Munich / Germany
  1. To understand the basics of cost-effectiveness analysis.
  2. To learn about the public health impact of hybrid imaging.
  3. To get familiar with the cost-effectiveness of contemporary hybrid imaging.
E³ 1119-5
16 min
Panel discussion: Where is the money, honey?

This session offers AI-generated subtitles.